Takeda bets $100M upfront on AC Immune's anti-amyloid Alzheimer's vaccine - Endpoints News
endpts.comSubmitted by endpointsnews6292 in business
AC Immune has lined up its third pharma partner in Alzheimer's disease, and the pact comes with a hefty biobucks package. Takeda will pay AC Immune $100 million upfront to snag the exclusive option to license the Swiss biotech's anti-amyloid vaccine, which is…